Company intelligence / Profile preview
Materia Medica Holding
Moscow, Russiamateriamedica.ru ↗
- Ownership
- Private
- Employees
- ~1400
- Development stage
- Other
01
Overview
The company has over 30 medications on the market, with several in clinical development. Their unique technology platform focuses on ultra-low doses of antibodies, combining homeopathy and modern pharmacology approaches.
- Therapeutic areas
- CardiovascularPsychiatryMen's HealthRheumatologyNeurologyInfectious Diseases
- Modalities
- Small moleculesMonoclonal antibodiesUltra-low doses of antibodies to endogenous regulators
- Industry
- Biotech
02
Drug pipeline
21 assets20 more assets in the full pipeline.
Beyond the preview
Go deeper on Materia Medica Holding.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Materia Medica Holding.